Philip Alfred Di Carlo, MD

Dr. Lilja Bjork Solnes is an Assistant Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her areas of clinical expertise include diagnostic radiology, oncology, and nuclear medicine. Dr. Solnes serves as the director of Nuclear Medicine and Molecular Imaging as well as the director of Radiotheranostics at the Johns Hopkins School of Medicine.Dr. Solnes received her M.B.A. and M.D. degrees from Columbia University College of Physicians and Surgeons. She completed her radiology residency at Columbia University Medical Center and performed fellowships in Radiology and Neuroradiology at Columbia University. She also completed fellowships from Ohio State University Wexner Medical Center in Neuroradiology and Cornell University Medical Center in Radiology.

Lew Romer has been an attending physician in the PICU since 2000. He is also a Co-Leader of the Pediatric Pulmonary Hypertension Program. As a senior faculty member in the PICU, Dr. Romer ensures that patients receive timely and outstanding quality of care. He oversees a patient’s entire care team, which includes fellows, junior faculty, residents, nurse practitioners, nurses, respiratory therapists, pharmacists, and Child Life specialists. He also forms treatment plans collaboratively with colleagues and other consultants in the treatment of pediatric patients with pulmonary hypertension.Dr. Romer has a research program that focuses on the study of endothelial cells – the cells that line all blood vessels. Endothelial cells are finely tuned to regulate the delivery of nutrients to cells, to serve as a barrier between the bloodstream and the tissues that make up all organ systems, and to ensure the unimpeded supply of blood flow. His laboratory team investigates endothelial cell adhesion and signaling during health and disease and works on tissue engineering blood vessels for both regenerative medicine and diagnostic drug-testing applications. Understanding how to optimize blood vessel function is a ubiquitous theme in the care of patients with critical illness. His work will increase our knowledge of how to improve blood vessel function, both through medications that regulate vessel caliber and by engineering new blood vessels that can increase blood supply to organs at-risk. He is also involved in research efforts to examine specific pharmacotherapies for pulmonary hypertension in children.Dr. Romer sees himself as both a micro- and macro-environmentalist. On the micro-scale, he studies the matrix environment in which cells live and how it changes the behavior and effectiveness of cells that form blood vessels. This microenvironment changes as a result of disease and disease therapy. He hopes to restore this microenvironment to normality or even to a state of super-normal potential for regeneration. On the macro scale, he is interested in creating a supportive educational environment for all caregivers in the PICU who must deal with extremely stressful situations. He believes that if we can create optimal educational tools and environmental cues for trainees and practitioners, we can better equip them to deal with the extremely challenging events that occur in the PICU. This will enable clinicians to focus better and provide better care.In his job, Dr. Romer enjoys taking care of children and their families and coordinating the team effort that it requires. He also enjoys teaching, scientific and translational research, and helping to foster the professional development of colleagues. When he is away from work, he enjoys Jewish studies, community service, thinking about the challenges that as yet have no answers, drawing, painting, bicycling, and making music.Dr. Romer attended Dartmouth College for undergraduate studies and then Dartmouth Medical School. He earned his MD in 1981 and went on to receive pediatric training at the University of Utah Primary Children’s Hospital. After a three-year stint in private practice as a general pediatrician/ NICU director/ PICU co-director/ and children’s air and ground transport service director in Northern Lower Michigan, he did a fellowship in pediatric critical care at the Children’s Hospital of Philadelphia (1987-1989) and a research fellowship in integrin-mediated adhesion and signaling at the Wistar Institute (1989-1990). His early years as a journeyman faculty investigator were spent in the lab of Professor Keith Burridge at the University of North Carolina at Chapel Hill, while Dr. Romer served as the Division Chief and Fellowship Director for Pediatric Critical Care Medicine.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics.